vTv Therapeutics Inc (VTVT)

[Amatuer17]

Looks like this stock is overlooked and has some good potential.

TTP488 -Alz drug - P3 trial enrollment completed and topline results expected in Q1-2018

TTP399 and TTP273 - diabetes - both have completed successful P2 trials
Both are oral drugs with not corresponding side effects - high potential

Company has decent amount of cash on hand - very low o/s shares - very low float - they can raise more money if they want without creating too many o/s shares

However as per 10-K, company is now looking for partners to start the P3 trials for diabetes drugs.

This makes the company in good position.

Background on TTP - VTVT was known as TransTech Pharma before they did IPO and listed the stocks. The TTP numbers are coming from that.

The IPO was done at $17 and it is trading at $6

In TTP days - they had collaboration with Pfizer, Novo but not sure now.

TTP488 - Pfizer did P2 and due to side effects at 20 mg abandoned the product - VTVT did P3 with more favorable lower dosage.

Looking at market cap, the P2/3 trials on 3 products and possibility of partnership for diabetes - this looks an attractive investment in my view.

Anyone with comments?